AgomAb Therapeutics NV Stock Price, News & Analysis
AGMB
Company Description
Welcome to the overview page for AgomAb Therapeutics NV (AGMB), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$15.27
+4.23%
+0.62
Last updated: February 6, 2026 at 17:05
-
Performance 1 year
$0.0
48.7M
SEC Filings
No SEC filings available for AgomAb Therapeutics NV.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
FEB
09
February 9, 2026
Financial
Offering expected to close
IPO expected to close; gross proceeds approx $200.0M before fees.
FEB
09
February 9, 2026 - March 11, 2026
Financial
Underwriter greenshoe option period
30-day underwriter option to purchase up to 1,875,000 ADSs after offering.
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of AgomAb Therapeutics NV (AGMB)?
The current stock price of AgomAb Therapeutics NV (AGMB) is $14.65 as of February 6, 2026.